Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.12 -0.08 (-0.61%)
At close: Oct 22, 2026 · 4:00 PM EDT

Eloxx Pharmaceuticals (ELOX) Receivables (2014)

Updated

Eloxx Pharmaceuticals' Receivables came in at $203,915 for Q2 2015, up 372.8% from the prior quarter.

Analysis

Eloxx Pharmaceuticals (ELOX) Receivables (2014) Analysis & Trends

At the end of FY2014, Eloxx Pharmaceuticals' Receivables was $43,133.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 18.99 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 13.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 5.06 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 12.49 Bn
10 Eloxx Pharmaceuticals 89.89 Mn 16.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 203,915.00
Sep 30, 2014 43,133.00
Jun 30, 2014 43,133.00
API Access

Eloxx Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ELOX&period=max&api_key=YOUR_API_KEY